Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Abemaciclib
Related studies linked through entity extraction aliases.
Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma
- Status
- UNKNOWN
- Phase
- PHASE2
Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Biomarker-driven, Open Label, Single Arm, Multicentre Phase II Study of Abemaciclib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Who Failed to Platinum-based Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6
- Status
- COMPLETED
- Phase
- PHASE2
Multiorgan Metabolic Imaging Response Assessment of Abemaciclib
- Status
- COMPLETED
- Phase
- PHASE2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- Status
- RECRUITING
- Phase
- PHASE2
Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)]
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Abemaciclib in Recurrent Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- Status
- RECRUITING
- Phase
- PHASE2
The Drug Rediscovery Protocol (DRUP Trial)
- Status
- RECRUITING
- Phase
- PHASE2